Hepatocyte regeneration is driven by embryo-like DNA methylation reprogramming.

DNA methylation dedifferentiation partial hepatectomy

Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
16 Apr 2024
Historique:
medline: 8 4 2024
pubmed: 8 4 2024
entrez: 8 4 2024
Statut: ppublish

Résumé

As a result of partial hepatectomy, the remaining liver tissue undergoes a process of renewed proliferation that leads to rapid regeneration of the liver. By following the early stages of this process, we observed dramatic programmed changes in the DNA methylation profile, characterized by both de novo and demethylation events, with a subsequent return to the original adult pattern as the liver matures. Strikingly, these transient alterations partially mimic the DNA methylation state of embryonic hepatoblasts (E16.5), indicating that hepatocytes actually undergo epigenetic dedifferentiation. Furthermore, Tet2/Tet3-deletion experiments demonstrated that these changes in methylation are necessary for carrying out basic embryonic functions, such as proliferation, a key step in liver regeneration. This implies that unlike tissue-specific regulatory regions that remain demethylated in the adult, early embryonic genes are programmed to first undergo demethylation, followed by remethylation as development proceeds. The identification of this built-in system may open targeting opportunities for regenerative medicine.

Identifiants

pubmed: 38588413
doi: 10.1073/pnas.2314885121
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2314885121

Subventions

Organisme : Wellcome Trust
ID : 210910
Pays : United Kingdom

Déclaration de conflit d'intérêts

Competing interests statement:The authors declare no competing interest.

Auteurs

Tal Falick Michaeli (T)

Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem 91120, Israel.
Sharett Institute of Oncology, Department of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.

Ofra Sabag (O)

Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem 91120, Israel.

Batia Azria (B)

Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem 91120, Israel.

Rimma Fok (R)

Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem 91120, Israel.

Nathalie Abudi (N)

The Goldyne Savad Institute of Gene Therapy, Hadassah Medical Organization, Jerusalem 91120, Israel.
The Wohl Institute for Translational Medicine, Hadassah Medical Organization, Jerusalem 91120, Israel.

Rinat Abramovitch (R)

The Goldyne Savad Institute of Gene Therapy, Hadassah Medical Organization, Jerusalem 91120, Israel.
The Wohl Institute for Translational Medicine, Hadassah Medical Organization, Jerusalem 91120, Israel.
Hebrew University Medical School, Bioinformatics Unit, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel.

Jonathan Monin (J)

Hebrew University Medical School, Bioinformatics Unit, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel.

Yuval Gielchinsky (Y)

Department of Obstetrics and Gynecology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.
Helen Schneider Hospital for Women, Rabin Medical Center, Petach Tikva 49100, Israel.

Howard Cedar (H)

Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem 91120, Israel.

Yehudit Bergman (Y)

Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem 91120, Israel.

Classifications MeSH